News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Protherics PLC Notification of Interim Results
November 9, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
London, 9 November 2007: Protherics PLC ("Protherics"), the biopharmaceutical company focused on critical care and cancer, will be announcing its interim results for the six months ended 30 September 2007, on Tuesday 20 November 2007.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Duchenne muscular dystrophy
Dyne gets early 2027 decision date for Duchenne therapy, analysts expect ‘smooth’ review
July 21, 2026
·
2 min read
·
Tristan Manalac
IPO
Axiom plans Hong Kong IPO, hoping to carve new path for US biotechs
July 21, 2026
·
3 min read
·
Gabrielle Masson
Psychedelics
Lilly’s AtaiBeckley buy validates space as Big Pharma takes note of psychedelics
July 20, 2026
·
3 min read
·
Heather McKenzie
IPO
2026 IPO class blooms again as BlossomHill, Latigo set sights on Nasdaq
July 20, 2026
·
2 min read
·
Tristan Manalac
